Casey Cosgrove
@CaseCos
Gynecologic Oncologist @osuccc_james
It’s amazing to work at a world class medical center @OSUWexMed - in a world class cancer hospital @OSUCCC_James - teaching phenomenal Med students @OhioStateMed and rooting for the nations best football team @OhioState @OhioStateFB
Starting the day with #ASCO25 Review at @OhioStateMedOnc with an stellar lineup of speakers with our chairs @AsrarAlahmadi & @AshishManne a great opportunity for an update and networking with our colleagues from Ohio! @LoganRoofMD @lingbin_meng @HasanovLab @OSUCCC_James
Great morning to discuss how clinical trials and research are improving the way we take care of our patient’s @OSUCCC_James
Great discussions and questions at the panel debate on the #ASCO25 Review at @OhioStateMedOnc @lingbin_meng @AsrarAlahmadi @LoganRoofMD @HasanovLab @DCarboneMD @AshishManne @OSUCCC_James
Join Ohio State experts to learn about the latest in oncology innovation at our 2025 ASCO review, 7/12 in Columbus. Click for info/registration: go.osu.edu/C6qH
Meet the talented team of endometrial cancer experts at the @OSUCCC_James. I’m proud to call them all colleagues, and honored to work alongside them to care for gynecologic cancer patients @OhioState. cancer.osu.edu/for-patients-a…
As an FSU alum and now an oncologist one of my favorite topics on rounds is the lifesaving work that Dr Holton performed. I’ll never forget organic chem class being asked how many enantiomer centers taxol had! @Seminoles @OSUCCC_James @FloridaState
The FSU family is deeply saddened by the passing of Florida State University alumnus and retired chemistry Professor Robert Holton. Dr. Holton’s groundbreaking synthesis of Taxol made the cancer drug widely available worldwide. His work saved countless lives and continues to…
The FSU family is deeply saddened by the passing of Florida State University alumnus and retired chemistry Professor Robert Holton. Dr. Holton’s groundbreaking synthesis of Taxol made the cancer drug widely available worldwide. His work saved countless lives and continues to…
Can’t wait to join an incredible group of speakers on an exciting list of topics!!!
💐This May let your knowledge bloom at IOG 2025! Join Dr. Ritu Salani, MD, MBA & Dr. Kathleen Moore, MD as they debate and discuss the latest diagnostic, therapeutic, and supportive care strategies for patients with gynecologic malignancies and more: tinyurl.com/545en9zs
Unfortunately the incidence of endometrial/uterine cancer is still going up.
News: Annual Report to the Nation: Cancer deaths continue to decline nih.gov/news-events/ne…
The annual report to the Nation on Cancer @AmericanCancer -> continued decline even during #covid period. acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
On behalf of the @OSUCCC_James, I welcome Dr. @KimrynRathmell to @OhioState. I look forward to working together to make The James an even more incredible place for oncology professionals to provide world-class care for our wonderful patients, and to break new ground in research.
I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3
I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3
Endometrial cancer too?!?!?
Agreed. In 2025, MSI and MMR IHC should be used to decide who gets immune checkpoint blockade therapy - not to decide who gets germline genetic testing.
Working group report from the 2024 NCI/GCSC endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era academic.oup.com/jnci/article-a… #gyncsm #endometrial @CaseCos and others
🙏 for @Seminoles
Dear FSU community, Today, we experienced a tragic and senseless act of violence at the heart of our campus. At lunchtime, an active shooter opened fire at the Student Union. Two were killed. Six others were injured. We are heartbroken. We are grieving with the families,…
🎤 Check out my interview with Dr. @DaniGlassman, a #GynOncology fellow at @OSUCCC_James 🏅 She is the recipient of the 2025 @GYNCancer FWC #Move4Her Research Grant 🧬 Watch as she talks about her research on #EndometrialCancer with a focus on the high-risk MMR-deficient…
Endometrial cancer somatic testing practice patterns among gynecologic oncologists @SGO_org @IGCSociety @ESGO_society @OncoAlert @ASCO sciencedirect.com/science/articl…
🚨Hot off the press 🗞️ Check out our article on contemporary practice patterns of somatic testing for endometrial cancer at the link below ⬇️ Thanks @gynoncjnls for publishing our commentary! @CaseCos @OSUCCC_James @SGO_org sciencedirect.com/science/articl…
Adding chemotherapy to radiotherapy was not associated with improved overall survival for patients with intermediate-risk cervical cancer. ja.ma/4kATTzM @nagustiga
Superstar fellow @OSUCCC_James doing incredible work! Congrats!
Thank you so much to @GYNCancer for awarding me the Move4Her Research Grant! So honored and grateful and ready to tackle heterogeneity in MMRd EC with @CaseCos as my mentor #sgomtg #SGO2025
Intriguing data for neoadjuvant #immunotherapy in resectable MMRd #endometrialcancer - high pathologic response rate but be careful of small n!!! Looking forward to C93 (pembrolizumab) and Domenica (dostarlimab) study results in advanced and recurrent disease #SGOMtg #gyncam